nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—S-Adenosylmethionine—COMT—conduct disorder	0.448	1	CrCbGaD
Cytarabine—POLB—brain—conduct disorder	0.0701	0.178	CbGeAlD
Cytarabine—POLD1—brain—conduct disorder	0.0573	0.145	CbGeAlD
Cytarabine—DCTD—brain—conduct disorder	0.0565	0.143	CbGeAlD
Cytarabine—NT5E—brain—conduct disorder	0.0437	0.111	CbGeAlD
Cytarabine—POLE—brain—conduct disorder	0.0428	0.108	CbGeAlD
Cytarabine—POLA1—brain—conduct disorder	0.0369	0.0935	CbGeAlD
Cytarabine—SLC29A1—brain—conduct disorder	0.0238	0.0603	CbGeAlD
Cytarabine—DCK—brain—conduct disorder	0.0228	0.0576	CbGeAlD
Cytarabine—ABCC10—brain—conduct disorder	0.0217	0.0549	CbGeAlD
Cytarabine—SLC22A1—brain—conduct disorder	0.0194	0.0491	CbGeAlD
Cytarabine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0152	0.0967	CbGpPWpGaD
Cytarabine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0151	0.096	CbGpPWpGaD
Cytarabine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0141	0.0901	CbGpPWpGaD
Cytarabine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.014	0.0895	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—WASF1—conduct disorder	0.00848	0.0541	CbGpPWpGaD
Cytarabine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00787	0.0502	CbGpPWpGaD
Cytarabine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00733	0.0468	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00569	0.0363	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CGA—conduct disorder	0.00407	0.0259	CbGpPWpGaD
Cytarabine—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00399	0.0255	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00374	0.0238	CbGpPWpGaD
Cytarabine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00372	0.0237	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00296	0.0189	CbGpPWpGaD
Cytarabine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00267	0.017	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0024	0.0153	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CGA—conduct disorder	0.00234	0.0149	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00224	0.0143	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CGA—conduct disorder	0.00214	0.0136	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—EP300—conduct disorder	0.00205	0.0131	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.00184	0.0117	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—COMT—conduct disorder	0.00184	0.0117	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—MAOA—conduct disorder	0.00182	0.0116	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00171	0.0109	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CGA—conduct disorder	0.00132	0.00845	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CGA—conduct disorder	0.00125	0.00794	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00115	0.00736	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00115	0.00731	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00108	0.00686	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00107	0.00681	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—COMT—conduct disorder	0.00105	0.00672	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MAOA—conduct disorder	0.00105	0.00667	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000988	0.0063	CbGpPWpGaD
Cytarabine—CDA—Metabolism—COMT—conduct disorder	0.000964	0.00615	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MAOA—conduct disorder	0.000957	0.0061	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000949	0.00605	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000921	0.00587	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—COMT—conduct disorder	0.000884	0.00564	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.000878	0.0056	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—COMT—conduct disorder	0.000824	0.00526	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000819	0.00522	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.000818	0.00522	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—EP300—conduct disorder	0.000787	0.00502	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—EP300—conduct disorder	0.000668	0.00426	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—EP300—conduct disorder	0.000645	0.00411	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—COMT—conduct disorder	0.000598	0.00381	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—EP300—conduct disorder	0.000597	0.00381	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MAOA—conduct disorder	0.000594	0.00379	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—EP300—conduct disorder	0.000577	0.00368	CbGpPWpGaD
Cytarabine—DCK—Metabolism—COMT—conduct disorder	0.000562	0.00359	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MAOA—conduct disorder	0.000558	0.00356	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CGA—conduct disorder	0.000493	0.00315	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CGA—conduct disorder	0.00046	0.00293	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—EP300—conduct disorder	0.000459	0.00293	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—EP300—conduct disorder	0.000452	0.00288	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000438	0.00279	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000435	0.00278	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000432	0.00276	CbGpPWpGaD
Cytarabine—CDA—Metabolism—EP300—conduct disorder	0.000413	0.00264	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—EP300—conduct disorder	0.000411	0.00262	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—EP300—conduct disorder	0.000256	0.00164	CbGpPWpGaD
Cytarabine—DCK—Metabolism—EP300—conduct disorder	0.000241	0.00154	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—COMT—conduct disorder	0.000223	0.00142	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MAOA—conduct disorder	0.000221	0.00141	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—COMT—conduct disorder	0.000208	0.00132	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000206	0.00131	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CGA—conduct disorder	0.000166	0.00106	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—EP300—conduct disorder	9.55e-05	0.000609	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—EP300—conduct disorder	8.9e-05	0.000568	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—COMT—conduct disorder	7.5e-05	0.000478	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MAOA—conduct disorder	7.44e-05	0.000475	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—EP300—conduct disorder	3.21e-05	0.000205	CbGpPWpGaD
